Latest News about ANAB
Recent news which mentions ANAB
Enliven Therapeutics, Alpine Immune Sciences, Janux Therapeutics And Other Big Stocks Moving Higher On Thursday
April 11, 2024
From Benzinga
Skin Disease-Focused AnaptysBio Earns Analyst Upgrade On Positive Outlook For Clinical Triggers
March 12, 2024
From Benzinga
Why Is Skin Disease Focused AnaptysBio Stock Trading Higher Today?
October 09, 2023
Tickers
ANAB
From Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
October 09, 2023
From Benzinga
Why Apellis Pharmaceuticals Shares Are Trading Lower By Around 19%? Here Are Other Stocks Moving In Monday's Session
July 31, 2023
From Benzinga
Stocks That Hit 52-Week Lows On Monday
July 24, 2023
From Benzinga
Stocks That Hit 52-Week Lows On Friday
July 21, 2023
From Benzinga
From Benzinga
GSK Unveils Detailed Phase 3 Data For Jemperli In Frontline Endometrial Cancer Patients
March 28, 2023
From Benzinga
Why Spruce Biosciences Shares Are Trading Higher By 100%? Here Are Other Stocks Moving In Friday's Mid-Day Session
January 06, 2023
From Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
January 06, 2023
From Benzinga
Greenbrier, Fate Therapeutics, AnaptysBio And Some Other Big Stocks Moving Lower On Friday
January 06, 2023
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For January 6, 2023
January 06, 2023
From Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
January 05, 2023
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For November 1, 2022
November 01, 2022
From Benzinga
AnaptysBio / GSK-Partnered Immuno-Oncology Agent Meets Primary Goal In Lung Cancer Trial
October 05, 2022
From Benzinga
HC Wainwright Sees 40% Upside For This Once Battered Stock With Pipeline Turnaround
September 19, 2022
Tickers
ANAB
From Benzinga
This Analyst Slashes PT On Rent the Runway By Around 43%, Plus JP Morgan Predicts $84 For Oracle
September 13, 2022
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 13, 2022
September 13, 2022
From Benzinga
AnaptysBio Sells Royalty Interest In Cancer Drug For $45M
September 12, 2022
From Benzinga
Raymond James Initiates AnaptysBio With ~42% Upside, Despite Trial Setback
September 02, 2022
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 1, 2022
September 01, 2022
From Benzinga
AnaptysBio Faces Another Setback For Imsidolimab, Stalls Work In Skin Scarring Indication
September 01, 2022
Tickers
ANAB
From Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
September 01, 2022
From Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
August 31, 2022
From Benzinga
From Benzinga
Stocks That Hit 52-Week Lows On Thursday
June 02, 2022
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Business Insurance is a singular, authoritative news and information source for executives focused upon risk management, risk transfer and risk financing.
Never miss important news. Subscribe to our newsletter.
Register for free
Information
Copyright 2024. BUSINESS INSURANCE HOLDINGS
